Science Resources RSS Feeds
|
 |
 |
 |
Antibody Current Events | Antibody News
|
| Page
1 of
13 |
252 Results |
|
|
|
Sort By:
Page Views | Date |
Antimicrobial antibodies in celiac disease: Trick or treat?
Anti-microbial antibody formation has been reported in celiac disease. view more (2009-08-27)
Researchers link specific antibody presence to prevention of mother-to-baby HIV transmission
Exploring why some HIV-positive mothers transmit the virus in utero to their babies while others don't, researchers from the UCLA AIDS Institute and Los Alamos National Laboratory studied 38 infant-mother pairs in the UCLA arm of the Los Angeles Pediatric AIDS Consortium. view more (2006-07-12)
Novel EGFR antibody outperforms cetuximab in mouse model of lung cancer
Antibodies that selectively bind and destroy cancer cells represent some of the most promising cancer therapy approaches being developed today. Several of these antibodies have reached the market, including cetuximab (Erbitux®, ImClone Systems), which targets the epidermal growth factor receptor (EGFR) protein. view more (2007-01-29)
Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson. view more (2009-09-02)
Computer Models Aid Understanding of Antibody-Dependent Enhancement in Spread of Dengue Fever
Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health. view more (2005-10-17)
New treatment hope for prostate cancer
Scientists at Melbourne's Burnet Institute have developed a potential new treatment for patients with prostate cancer. An article, which described the invention, has recently been published in the prestigious international journal The Journal of Clinical Investigation. view more (2009-02-06)
Antibody key to treating variant CJD, scientists find
Scientists at the University of Liverpool have determined the atomic structure of the 'binding' between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD. view more (2009-03-04)
How to beat superbugs
HOSPITALS in Britain will next week begin testing a drug against superbugs that mimics the antibodies produced by our immune systems. With superbugs fast developing resistance to every antibiotic we can throw at them, alternative treatments are urgently needed. In 1990, 2 per cent of Staphylococcus... view more... (2002-05-23)
Antibody-based therapies effective at controlling malaria
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S. McIntosh from the University of Nottingham in a paper published this week in the open-access journal PLoS Pathogens. view more (2007-05-18)
Novel and Effective Treatment for Soft Tissue Sarcoma in Children
Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys. The most common age for onset is between 1-5 years of age. The treatments... view more... (2004-07-15)
UCLA researchers identify how antibody blocks prostate cancer growth in animal models
Researchers at UCLA's Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy. view more (2005-10-18)
Scripps research team develops new technique to tap full potential of antibody libraries
In hopes of more fully tapping the libraries' potential, a group of Scripps Research Institute scientists, led by Scripps Research President Richard A. Lerner, M.D., has for the first time developed a new screening technique that enables antibody screening against equally massive libraries of targets. view more (2009-01-16)
Effective preventive drug against bird flu developed in the mouse
Researchers have developed what could be used as an effective preventive drug against bird flu. view more (2006-10-13)
New study shows antibody-interleukin complexes stimulate immune responses
The findings could also be significant for developing new ways to help patients with autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, or juvenile diabetes. view more (2006-02-23)
New molecular imaging techniques may lead to advances in disease treatment
A promising new technique has been developed that will enable more accurate non-invasive positron emission tomography (PET) imaging of new cells injected into the body, according to researchers at SNM's 55th Annual Meeting. view more (2008-06-17)
Aetiology of congenital heart disease explained
Researchers at Karolinska Institutet have identified the mechanisms behind the serious, congenital heart condition that can sometimes develop in children of women with a rheumatic disease. view more (2005-02-07)
Flu virus foiled again
Researchers at The Scripps Research Institute in La Jolla, California, supported in part by the National Institutes of Health, have identified a common Achilles' heel in a wide range of seasonal and pandemic influenza A viruses. view more (2009-02-27)
Second Generation Targeted Antibodies - It's All in the Binding
(Melbourne, May 7th) -- The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry. Now, just weeks after one of the first anti-EGFR antibodies,... view more... (2004-05-06)
Xerion Pharmaceuticals and Arius Research sign colon cancer collaboration
Martinsried, Germany and Cambridge, Massachusetts, USA - October 15, 2002"¦Xerion Pharmaceuticals and ARIUS Research Inc. of Canada announced today that they would combine their respective strengths in functional proteomics and antibody discovery to jointly develop products for cancer therapy. Xerion will take four antibodies from ARIUS'... view more... (2002-10-15)
Producing medicines in plant seeds
Using plants to produce useful proteins could be an inexpensive alternative to current medicine production methods. Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) at Ghent University have succeeded in producing in plant seeds proteins that have a very strong resemblance to antibodies. view more (2007-01-17)
|
|
| Page
1 of
13 |
252 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
